Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results
- Reports Full-Year Diluted EPS of $3.30 on a GAAP Basis; Adjusted Diluted EPS of $5.60 Reflects Growth of 16.2 Percent - Delivers Full-Year Net Revenues of $28.216 Billion; Adjusted Net Revenues Increased 10.1 Percent on an Operational Basis - Full-Year Global HUMIRA Sales of $18.427 Billion
Toggle Summary AbbVie to Host Fourth-Quarter 2017 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 12, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its fourth-quarter 2017 financial results on Friday, Jan. 26, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the 36th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 20, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10:30 a.m. Central time .
Toggle Summary AbbVie to Present at the Goldman Sachs 10th Annual Healthcare CEOs Unscripted: A View from the Top
NORTH CHICAGO, Ill. , Dec. 19, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 10th Annual Healthcare CEOs Unscripted: A View from the Top on Thursday, January 4, 2018 . Richard A. Gonzalez, chairman and chief executive officer, will present at 10 a.m. Central time .
Toggle Summary AbbVie to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
NORTH CHICAGO, Ill. , Nov. 15, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference on Wednesday, November 29, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 7 a.m. Central time .
Toggle Summary AbbVie to Present at the Jefferies 2017 London Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 3, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 London Healthcare Conference on Thursday, Nov. 16, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 3:20 a.m. Central time .
Toggle Summary AbbVie Reports Third-Quarter 2017 Financial Results
- Reports Third-Quarter Diluted EPS of $1.01 on a GAAP Basis; Adjusted Diluted EPS of $1.41, Reflecting Growth of 16.5 Percent - Delivers Third-Quarter Net Revenues of $6.995 Billion; Adjusted Net Revenues Increased 8.8 Percent on an Operational Basis - Third-Quarter Global HUMIRA Sales of $4.701
Toggle Summary AbbVie Increases Quarterly Dividend by 11 Percent
NORTH CHICAGO, Ill. , Oct. 27, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 11 percent from $0.64 per share to $0.71 per share.  The cash dividend is payable February 15, 2018 to shareholders of record at the close of
Toggle Summary AbbVie to Present at the 2017 Credit Suisse Health Care Conference
NORTH CHICAGO, Ill. , Oct. 18, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 12 p.m. Central time .
Toggle Summary AbbVie to Host Third-Quarter 2017 Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 9, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2017 financial results on Friday, Oct. 27, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).